Annual Accounts Payable
$1.67 M
+$827.60 K+98.20%
December 31, 2023
Summary
- As of February 26, 2025, APRE annual accounts payable is $1.67 million, with the most recent change of +$827.60 thousand (+98.20%) on December 31, 2023.
- During the last 3 years, APRE annual accounts payable has fallen by -$2.83 million (-62.91%).
- APRE annual accounts payable is now -62.91% below its all-time high of $4.50 million, reached on December 31, 2020.
Performance
APRE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.15 M
+$189.60 K+19.66%
September 30, 2024
Summary
- As of February 26, 2025, APRE quarterly accounts payable is $1.15 million, with the most recent change of +$189.60 thousand (+19.66%) on September 30, 2024.
- Over the past year, APRE quarterly accounts payable has dropped by -$164.50 thousand (-12.48%).
- APRE quarterly accounts payable is now -78.80% below its all-time high of $5.44 million, reached on June 30, 2020.
Performance
APRE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
APRE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +98.2% | -12.5% |
| 3 y3 years | -62.9% | -54.7% |
| 5 y5 years | -4.0% | -67.1% |
APRE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | +98.2% | -71.1% | +39.7% |
| 5 y | 5-year | -62.9% | +98.2% | -78.8% | +39.7% |
| alltime | all time | -62.9% | >+9999.0% | -78.8% | +39.7% |
Aprea Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.15 M(+19.7%) |
| Jun 2024 | - | $964.30 K(-26.9%) |
| Mar 2024 | - | $1.32 M(-21.1%) |
| Dec 2023 | $1.67 M(+98.2%) | $1.67 M(+93.6%) |
| Sep 2023 | - | $862.60 K(-23.7%) |
| Jun 2023 | - | $1.13 M(+36.9%) |
| Mar 2023 | - | $826.00 K(-2.0%) |
| Dec 2022 | $842.80 K(-52.5%) | $842.80 K(-25.8%) |
| Sep 2022 | - | $1.14 M(-71.5%) |
| Jun 2022 | - | $3.99 M(+100.7%) |
| Mar 2022 | - | $1.99 M(+12.1%) |
| Dec 2021 | $1.77 M | $1.77 M(-30.4%) |
| Sep 2021 | - | $2.55 M(+7.9%) |
| Jun 2021 | - | $2.36 M(-31.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $3.46 M(-23.2%) |
| Dec 2020 | $4.50 M(+106.9%) | $4.50 M(+3.5%) |
| Sep 2020 | - | $4.35 M(-20.1%) |
| Jun 2020 | - | $5.44 M(+81.0%) |
| Mar 2020 | - | $3.01 M(+38.1%) |
| Dec 2019 | $2.18 M(+25.2%) | $2.18 M(-38.0%) |
| Sep 2019 | - | $3.51 M(+51.1%) |
| Jun 2019 | - | $2.32 M(+33.6%) |
| Dec 2018 | $1.74 M(+4.7%) | $1.74 M |
| Dec 2017 | $1.66 M(+895.1%) | - |
| Jun 2008 | $167.00 K(-46.7%) | - |
| Jun 2007 | $313.20 K(-16.7%) | - |
| Jun 2006 | $375.80 K(>+9900.0%) | - |
| Dec 2004 | $3300.00 | - |
FAQ
- What is Aprea Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Aprea Therapeutics?
- What is Aprea Therapeutics annual accounts payable year-on-year change?
- What is Aprea Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly accounts payable year-on-year change?
What is Aprea Therapeutics annual accounts payable?
The current annual accounts payable of APRE is $1.67 M
What is the all time high annual accounts payable for Aprea Therapeutics?
Aprea Therapeutics all-time high annual accounts payable is $4.50 M
What is Aprea Therapeutics annual accounts payable year-on-year change?
Over the past year, APRE annual accounts payable has changed by +$827.60 K (+98.20%)
What is Aprea Therapeutics quarterly accounts payable?
The current quarterly accounts payable of APRE is $1.15 M
What is the all time high quarterly accounts payable for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly accounts payable is $5.44 M
What is Aprea Therapeutics quarterly accounts payable year-on-year change?
Over the past year, APRE quarterly accounts payable has changed by -$164.50 K (-12.48%)